Enyo Pharma Is A Clinical Stage Biopharmaceutical Company Based In Lyonfrancefounded In January 2014 By Scientists From The Infectiology Research Centerthe Company Is Dedicated To Developing Innovative Therapeutics For Diseases Affecting Kidney And Liver Functionutilizing A Unique Drug Discovery Platform Inspired By Virus Biomimetism The Company S Lead Compoundvonafexoris A Small Molecule With Anti Inflammatory And Fibrolytic Propertiesit Is Currently In Phase 2 Development For Chronic Kidney Diseasesckd Alport Syndromeand Liver Diseases Such As Metabolic Dysfunction Associated Steatohepatitismash Enyo Pharma Is Also Exploring Treatments For Liver Related Infectious Diseasesincluding Chronic Hepatitis B And Hepatitis Dwith A Revenue Of Approximately $7 Million And A Team Of Around 35 Employeesenyo Pharma Is Actively Engaged In Research And Development To Advance Its Therapeutic Offerings
